Geoffrey Chupp

13.0k total citations · 7 hit papers
122 papers, 8.1k citations indexed

About

Geoffrey Chupp is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Geoffrey Chupp has authored 122 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Physiology, 41 papers in Pulmonary and Respiratory Medicine and 31 papers in Molecular Biology. Recurrent topics in Geoffrey Chupp's work include Asthma and respiratory diseases (74 papers), Respiratory and Cough-Related Research (23 papers) and IL-33, ST2, and ILC Pathways (21 papers). Geoffrey Chupp is often cited by papers focused on Asthma and respiratory diseases (74 papers), Respiratory and Cough-Related Research (23 papers) and IL-33, ST2, and ILC Pathways (21 papers). Geoffrey Chupp collaborates with scholars based in United States, United Kingdom and France. Geoffrey Chupp's co-authors include Jack A. Elias, Lauren Cohn, Robert Homer, Zhou Zhu, Ravdeep Kaur, Jeffrey S. Berman, Chun Geun Lee, Gerard J. Nau, Hardy Kornfeld and Carole Ober and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Geoffrey Chupp

115 papers receiving 7.9k citations

Hit Papers

A sthma : Mechanisms of Disease Persistence and Progression 1999 2026 2008 2017 2004 2021 1999 2017 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A sthma : Mechanisms of Disease Persistence and Progression
    2004 667 citations Lauren Cohn, Jack A. Elias et al. profile →
  2. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
    2021 606 citations Andrew Menzies‐Gow, Arnaud Bourdin et al. profile →
  3. Airway remodeling in asthma
    1999 584 citations Jack A. Elias, Zhou Zhu et al. profile →
  4. Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
    2017 430 citations Geoffrey Chupp et al. profile →
  5. Phenotypes and endotypes of adult asthma: Moving toward precision medicine
    2019 303 citations Geoffrey Chupp et al. Journal of Allergy and Clinical Immunology profile →
  6. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
    2021 195 citations Steven G. Kelsen, Ioana Agache et al. Journal of Allergy and Clinical Immunology profile →
  7. Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials
    2023 95 citations Andrew Menzies‐Gow, Geoffrey Chupp et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey Chupp United States 42 3.8k 2.8k 2.5k 2.1k 1.1k 122 8.1k
Christian Taube Germany 54 3.9k 1.0× 2.9k 1.1× 3.8k 1.5× 1.2k 0.6× 1.6k 1.5× 353 9.4k
Mirjam Kool Netherlands 40 2.4k 0.6× 1.5k 0.6× 4.4k 1.8× 1.7k 0.8× 599 0.5× 90 7.8k
Charles McSharry United Kingdom 46 2.4k 0.6× 2.3k 0.8× 2.3k 0.9× 1.1k 0.5× 931 0.8× 128 7.2k
Ken Ohta Japan 42 4.0k 1.1× 2.7k 1.0× 2.2k 0.9× 557 0.3× 1.0k 0.9× 286 7.0k
Mark D. Inman Canada 53 5.6k 1.5× 4.0k 1.5× 2.2k 0.9× 1.2k 0.5× 806 0.7× 157 8.9k
Lanny J. Rosenwasser United States 52 3.6k 1.0× 1.7k 0.6× 3.7k 1.5× 1.6k 0.8× 1.1k 1.0× 186 9.6k
Farrah Kheradmand United States 45 2.4k 0.6× 2.6k 1.0× 2.0k 0.8× 1.9k 0.9× 638 0.6× 142 7.7k
Eckard Hamelmann Germany 56 6.3k 1.7× 2.7k 1.0× 3.3k 1.3× 1.4k 0.7× 778 0.7× 265 10.6k
David B. Corry United States 57 5.3k 1.4× 3.0k 1.1× 5.5k 2.2× 2.1k 1.0× 1.0k 0.9× 166 12.8k
Donata Vercelli United States 53 3.8k 1.0× 1.3k 0.5× 4.7k 1.9× 1.5k 0.7× 581 0.5× 168 9.6k

Countries citing papers authored by Geoffrey Chupp

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Chupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Chupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Chupp more than expected).

Fields of papers citing papers by Geoffrey Chupp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Chupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Chupp. The network helps show where Geoffrey Chupp may publish in the future.

Co-authorship network of co-authors of Geoffrey Chupp

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Chupp. A scholar is included among the top collaborators of Geoffrey Chupp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Chupp. Geoffrey Chupp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caruso, Cristiano, Giorgio Walter Canonica, Manish Patel, et al.. (2024). Prospective REALITI-A Study. SHILAP Revista de lepidopterología. 3(1). 100107–100107. 3 indexed citations
2.
Buchheit, Kathleen M., Dominick Shaw, Geoffrey Chupp, et al.. (2024). Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils. Allergy. 79(10). 2662–2679. 21 indexed citations
3.
4.
Bourdin, Arnaud, et al.. (2024). MELTEMI and COLUMBA: 5-Year Comparative Safety Analysis of Benralizumab and Mepolizumab. The Journal of Allergy and Clinical Immunology In Practice. 12(8). 2074–2083.e4. 5 indexed citations
5.
6.
Zaeh, Sandra E., Michelle N. Eakin, & Geoffrey Chupp. (2023). Clinical Practices and Barriers to the Use of Single Maintenance and Reliever Therapy for Asthma. A6006–A6006. 1 indexed citations
7.
Rabe, Klaus F., Ian Pavord, William W. Busse, et al.. (2023). Dupilumab improves long‐term outcomes in patients with uncontrolled, moderate‐to‐severe GINA‐based type 2 asthma, irrespective of allergic status. Allergy. 78(8). 2148–2156. 6 indexed citations
8.
Kelsen, Steven G., Ioana Agache, Weily Soong, et al.. (2021). Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. Journal of Allergy and Clinical Immunology. 148(3). 790–798. 195 indexed citations breakdown →
9.
Chen, Ailu, Miguel F. Sanmamed, Taylor Adams, et al.. (2021). Single-cell characterization of a model of poly I:C-stimulated peripheral blood mononuclear cells in severe asthma. Respiratory Research. 22(1). 9 indexed citations
10.
Wang, Alberta L., Ronald Allan M. Panganiban, Weiliang Qiu, et al.. (2021). Drug Repurposing to Treat Glucocorticoid Resistance in Asthma. Journal of Personalized Medicine. 11(3). 175–175. 11 indexed citations
11.
Kho, Alvin T., Michael J. McGeachie, Jiang Li, et al.. (2021). Lung function, airway and peripheral basophils and eosinophils are associated with molecular pharmacogenomic endotypes of steroid response in severe asthma. Thorax. 77(5). 452–460. 3 indexed citations
12.
Gómez, José L., Ailu Chen, María P. Díaz, et al.. (2020). A Network of Sputum MicroRNAs Is Associated with Neutrophilic Airway Inflammation in Asthma. American Journal of Respiratory and Critical Care Medicine. 202(1). 51–64. 49 indexed citations
13.
Schupp, Jonas C., Sara Khanal, José L. Gómez, et al.. (2020). Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 202(10). 1419–1429. 44 indexed citations
14.
Spakowicz, Daniel, Shaoke Lou, José L. Gómez, et al.. (2020). Approaches for integrating heterogeneous RNA-seq data reveal cross-talk between microbes and genes in asthmatic patients. Genome biology. 21(1). 150–150. 4 indexed citations
15.
Yan, Xiting, J Chu, José L. Gómez, et al.. (2016). Noninvasive Analysis of the Sputum Transcriptome Discriminates Clinical Phenotypes of Asthma. Annals of the American Thoracic Society. 13(Supplement_1). S104–S105. 13 indexed citations
16.
Ahangari, Farida, Anil K. Sood, Bing Ma, et al.. (2015). Chitinase 3–Like-1 Regulates Both Visceral Fat Accumulation and Asthma-like Th2 Inflammation. American Journal of Respiratory and Critical Care Medicine. 191(7). 746–757. 70 indexed citations
17.
Yan, Xiting, J Chu, José L. Gómez, et al.. (2015). Noninvasive Analysis of the Sputum Transcriptome Discriminates Clinical Phenotypes of Asthma. American Journal of Respiratory and Critical Care Medicine. 191(10). 1116–1125. 62 indexed citations
18.
Lee, Naeun, Sungyong You, Min Sun Shin, et al.. (2014). IL-6 Receptor α Defines Effector Memory CD8+ T Cells Producing Th2 Cytokines and Expanding in Asthma. American Journal of Respiratory and Critical Care Medicine. 190(12). 1383–1394. 33 indexed citations
19.
Zhu, Zhou, Chun Geun Lee, Tao Zheng, et al.. (2001). Airway Inflammation and Remodeling in Asthma. American Journal of Respiratory and Critical Care Medicine. 164(Supplement_2). S67–S70. 76 indexed citations
20.
Chupp, Geoffrey, et al.. (1998). Tissue and T Cell Distribution of Precursor and Mature IL-16. The Journal of Immunology. 161(6). 3114–3119. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Taube Breakdown of academic impact, for papers by Mirjam Kool Breakdown of academic impact, for papers by Charles McSharry Breakdown of academic impact, for papers by Ken Ohta Breakdown of academic impact, for papers by Mark D. Inman Breakdown of academic impact, for papers by Lanny J. Rosenwasser Breakdown of academic impact, for papers by Farrah Kheradmand Breakdown of academic impact, for papers by Eckard Hamelmann Breakdown of academic impact, for papers by David B. Corry Breakdown of academic impact, for papers by Donata Vercelli
Rankless by CCL
2026